aDepartment of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA
bDepartment of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany
cGSK Global Specialty and Primary Care, London, United Kingdom
dGSK Medicines Research Centre, Stevenage, United Kingdom
The authors declare a conflict of interest. Professor Wagenlehner has the following disclosures: personal fees from GlaxoSmithKline (outside the submitted work). Professor Stapleton has the following disclosures: personal fees from GlaxoSmithKline (outside the submitted work). Dr Mulgirigama and M. Twynholm are employees of GlaxoSmithKline.